Drug Addiction News

Cordant Provides Telemedicine Resolution for Drug Testing to Assist Present Essential Care to Addiction and Psychological Well being Sufferers Throughout COVID-19 Pandemic – The Grand Junction Day by day Sentinel

DENVER April a Providing Critical Care 8, 2020 / PRNewswire / – Cordant Health Solutions® (Cordant) provides a video-watched oral liquid drug test solution that is ideal for addiction treatment organizations and government agencies to help people recover from a substance use disorder continue to provide critical care. Oral fluid tests are an effective tool that, according to the American Society of Addiction Medicine, has been recognized as a suitable matrix for testing in addiction treatment environments.

Due to widespread "shelter-in-place" orders and in order to minimize exposure to COVID-19, many clinicians and government agencies have difficulty adhering to their treatment protocols and programs. While many may already offer telemedicine, services such as drug testing to monitor compliance in this environment are challenging.

Video-observed oral fluid tests are non-invasive, easy to observe, and can be conveniently performed at the patient's home, reducing the risk of exposure to COVID-19. The entire HIPAA-compliant process is carried out under video surveillance by a remote Cordant collection specialist or by the clinician during a telemedicine appointment.

"The continuity of care is particularly critical at this point, since any addiction treatment disorder is combined. With the increased stress and uncertainty caused by the current pandemic, the likelihood of relapse in this vulnerable population may increase be increased, "said Sue Sommer CEO and President of Cordant. "The ability to offer drug monitoring for telemedicine helps keep addicts accountable for their treatment program and provides doctors with objective insight into patient compliance at a time when they can't see the patient that often."

For patients taking buprenorphine, a drug used to treat opioid use disorders, the Cordant oral fluid test detects extremely low buprenorphine levels, minimizing false negative results, and makes it a useful test option for addiction and drug-assisted prescribers . Cordant also currently has one of the largest mental health testing menus, with the ability to test 55 mental health drugs with saliva.

To further improve patient safety, Cordant offers a pharmacy solution that can help make patients comfortable and reliable access to buprenorphine. The drug can be delivered either at home or at the patient's time at the clinic, reducing unnecessary travel. This program is also available for clinics that use telemedicine to treat addiction.

According to the Agency for Drug Abuse and Mental Health (SAMHSA), Americans across the country will struggle with increasing depression, anxiety, trauma, and grief. There is also an expected increase in substance abuse as the lives of individuals and families are affected.

SAMHSA and the Drug Enforcement Administration (DEA) have sought to offer flexibility in prescribing and dispensing controlled substances to ensure the necessary addiction. Treatment remains accessible to the public during this emergency. At this point, the DEA announced that doctors could prescribe controlled substances to patients using telemedicine without first making a personal public health assessment during this emergency.

"The COVID-19 pandemic has had so many ramifications in our country today, and addiction treatment patients were hit when clinics made the difficult decision to close or find ways to quickly care for their patients quickly "said Sommer. "It is a reward to be able to offer services like our pharmacy program or our video drug tests that enable organizations to provide a high level of treatment to their patients in this uncertain time."

To learn how to add Cordants solution for your program, contact Cordant at sales@cordanths.com or 844-848-5955.

About Cordant Health Solutions®

Cordant Health Solutions® (www.cordantsolutions.com) provides innovative tools for monitoring behavioral disorders, chronic pain, and criminal matters. Our unique pharmacy and drug testing programs deliver accurate, actionable results to protect prescribers, hold patients accountable, and optimize quality of life.

As a leading provider of quality standards, Cordant is committed to developing solutions for payers, clinicians and doctors organizations dealing with drug use disorders, pain management and law enforcement agencies. Cordant is one of the few healthcare companies to offer monitoring and risk assessment tools through its innovative drug testing options and full-service, high-touch pharmacies that specialize in the complex management and delivery of controlled substances.

Media contact:
Tiffany Tuetken

Related Images

Cordant Health Solutions

Related Articles